Liu KS et al. |
Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial. |
2014 |
Gut |
pmid:24295850
|
Miwa S et al. |
Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study. |
2014 |
Ann Am Thorac Soc |
pmid:24298907
|
Lara-MartÃn PA et al. |
Occurrence, distribution and partitioning of nonionic surfactants and pharmaceuticals in the urbanized Long Island Sound Estuary (NY). |
2014 |
Mar. Pollut. Bull. |
pmid:24467856
|
Saadat A et al. |
The formulation, chemical and physical characterisation of clarithromycin-based macrolide solution pressurised metered dose inhaler. |
2014 |
J. Pharm. Pharmacol. |
pmid:24329164
|
Rajput P et al. |
Bifunctional capsular dosage form: novel fanicular cylindrical gastroretentive system of clarithromycin and immediate release granules of ranitidine HCl for simultaneous delivery. |
2014 |
Int J Pharm |
pmid:24309435
|
Katayama M et al. |
Preliminary study of effects of multiple oral dosing of clarithromycin on the pharmacokinetics of cyclosporine in dogs. |
2014 |
J. Vet. Med. Sci. |
pmid:24189617
|
Ratzinger F et al. |
Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity. |
2014 |
Sci Rep |
pmid:25500904
|
Kato M |
[Expanded indication of National Health Insurance for H. pylori associated gastritis]. |
2014 |
Nippon Rinsho |
pmid:24912302
|
Trotti LM et al. |
Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: Clinical experience. |
2014 |
J. Psychopharmacol. (Oxford) |
pmid:24306133
|
Noh TK et al. |
Infection with Mycobacterium fortuitum during acupoint embedding therapy. |
2014 |
J. Am. Acad. Dermatol. |
pmid:24831334
|
Fowler J and Mahlen SD |
Localized cutaneous infections in immunocompetent individuals due to rapidly growing mycobacteria. |
2014 |
Arch. Pathol. Lab. Med. |
pmid:25076301
|
Ueda Y et al. |
[Obstructive pneumonia and brain abscess due to Nocardia elegans in a patient with systemic lupus erythematosus]. |
2014 |
Kansenshogaku Zasshi |
pmid:24974451
|
NegrÃn-González J et al. |
Psychiatric adverse reaction induced by clarithromycin. |
2014 |
Eur Ann Allergy Clin Immunol |
pmid:24853570
|
Nie W et al. |
[The analysis of species identification and susceptibility testing of Mycobacterium abscessus]. |
2014 |
Zhonghua Jie He He Hu Xi Za Zhi |
pmid:25262693
|
Kurosaki Y et al. |
[Two cases of pulmonary Mycobacterium avium complex disease with resistance to clarithromycin]. |
2014 |
Kekkaku |
pmid:24979948
|
Iwanaga K and Carter ER |
Mycobacterium abscessus complex lung infection in a toddler with a tracheostomy. |
2014 |
Pediatr. Pulmonol. |
pmid:23460506
|
Kim SY et al. |
Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease. |
2014 |
Clin. Exp. Immunol. |
pmid:24354934
|
De Francesco V et al. |
Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy. |
2014 |
J. Med. Microbiol. |
pmid:24344205
|
Oztürk K et al. |
Diagnosis of helicobacter pylori infection. |
2014 |
Turk J Gastroenterol |
pmid:25141328
|
Lee JY et al. |
Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance. |
2014 |
Dig. Dis. Sci. |
pmid:24599773
|
Zhao HM et al. |
[Clinical effect of triple therapy combined with Saccharomyces boulardii in the treatment of Helicobacter pylori infection in children]. |
2014 |
Zhongguo Dang Dai Er Ke Za Zhi |
pmid:24661511
|
Ohe M and Hashino S |
Successful treatment of primary immune thrombocytopenia in aged patients using clarithromycin. |
2014 |
J. Formos. Med. Assoc. |
pmid:24630039
|
Zhou L et al. |
A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial. |
2014 |
Am. J. Gastroenterol. |
pmid:24642580
|
Heo J and Jeon SW |
[Changes in the eradication rate of conventional triple therapy for Helicobacter pylori infection in Korea]. |
2014 |
Korean J Gastroenterol |
pmid:24651586
|
Kang BK et al. |
[New therapeutic strategies against Helicobacter pylori]. |
2014 |
Korean J Gastroenterol |
pmid:24651587
|
Lee JY and Kim N |
[Future trends of Helicobacter pylori eradication therapy in Korea]. |
2014 |
Korean J Gastroenterol |
pmid:24651589
|
Lee SH et al. |
The drug resistance profile of Mycobacterium abscessus group strains from Korea. |
2014 |
Ann Lab Med |
pmid:24422193
|
Oğuz M and Mihçiokur H |
Environmental risk assessment of selected pharmaceuticals in Turkey. |
2014 |
Environ. Toxicol. Pharmacol. |
pmid:24929476
|
Peedikayil MC et al. |
Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials. |
2014 |
PLoS ONE |
pmid:24465624
|
Yoshida N et al. |
A cross-sectional investigation of the quality of selected medicines in Cambodia in 2010. |
2014 |
BMC Pharmacol Toxicol |
pmid:24593851
|
Vu DH et al. |
Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC-MS/MS. |
2014 |
Talanta |
pmid:24607103
|
Zaiem A et al. |
Clarithromycin induced psoriasis in a 37-year old man. |
2014 |
Curr Drug Saf |
pmid:24410388
|
de Masson A et al. |
Cavitary pulmonary disease in a patient treated with natalizumab. |
2014 |
Presse Med |
pmid:24742610
|
Furuta T et al. |
Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan. |
2014 |
J. Gastroenterol. Hepatol. |
pmid:24224808
|
Page SR and Yee KC |
Rhabdomyolysis in association with simvastatin and dosage increment in clarithromycin. |
2014 |
Intern Med J |
pmid:25041770
|
Noguchi S et al. |
Polymorphic transformation of antibiotic clarithromycin under acidic condition. |
2014 |
J Pharm Sci |
pmid:24375227
|
Phillips RO et al. |
Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24323473
|
McNicholl AG et al. |
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice. |
2014 |
Gut |
pmid:23665990
|
Komiya K et al. |
Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis. |
2014 |
Int. J. Antimicrob. Agents |
pmid:24948577
|
Homma S et al. |
The successful management of respiratory complications with long-term, low-dose macrolide administration in pediatric heart transplant recipients. |
2014 |
Int Heart J |
pmid:25297501
|
Renvoisé A et al. |
Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare. |
2014 |
J. Clin. Microbiol. |
pmid:25274991
|
Tu S and Yang H |
[Progress in the treatment of Helicobacter pylori infection]. |
2014 |
Zhong Nan Da Xue Xue Bao Yi Xue Ban |
pmid:25269503
|
Malfertheiner P and Selgrad M |
Helicobacter pylori. |
2014 |
Curr. Opin. Gastroenterol. |
pmid:25268839
|
Ito Y et al. |
The influence of environmental exposure on the response to antimicrobial treatment in pulmonary Mycobacterial avium complex disease. |
2014 |
BMC Infect. Dis. |
pmid:25266993
|
de Miguel-Martinez I et al. |
[Bacteriemia due to Mycobacterium canariasense in an oncohematological patient with a long-term central device]. |
2014 |
Enferm. Infecc. Microbiol. Clin. |
pmid:25262854
|
Gui J et al. |
[Subspecies identification for Mycobacterium abscessus group]. |
2014 |
Zhonghua Jie He He Hu Xi Za Zhi |
pmid:25262692
|
Ghrew MH et al. |
Successful renal transplant in patient with controlled pulmonary non-tuberculous mycobacterium infection. |
2014 |
Libyan J Med |
pmid:25249307
|
Yoon KH et al. |
Clarithromycin-based standard triple therapy can still be effective for Helicobacter pylori eradication in some parts of the Korea. |
2014 |
J. Korean Med. Sci. |
pmid:25246742
|
Higgins JW et al. |
Clinical CYP3A inhibitor alternatives to ketoconazole, clarithromycin and itraconazole, are not transported into the liver by hepatic organic anion transporting polypeptides and organic cation transporter 1. |
2014 |
Drug Metab. Dispos. |
pmid:25106415
|
Matongo F and Nwodo UU |
In vitro assessment of Helicobacter pylori ureases inhibition by honey fractions. |
2014 |
Arch. Med. Res. |
pmid:25240315
|
Boleda MR et al. |
Survey of the occurrence of pharmaceuticals in Spanish finished drinking waters. |
2014 |
Environ Sci Pollut Res Int |
pmid:24756682
|
Nilsson MF and Webster WS |
Effects of macrolide antibiotics on rat embryonic heart function in vitro. |
2014 |
Birth Defects Res. B Dev. Reprod. Toxicol. |
pmid:24753334
|
Wallace RJ et al. |
Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease. |
2014 |
Chest |
pmid:24457542
|
Molina-Infante J and Gisbert JP |
Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance. |
2014 |
World J. Gastroenterol. |
pmid:25132750
|
Heo J et al. |
A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication. |
2014 |
Dig Liver Dis |
pmid:25132282
|
Lebedeva MV et al. |
Clarithromycin as a chiral selector for enantioseparation of basic compounds in nonaqueous capillary electrophoresis. |
2014 |
Electrophoresis |
pmid:25100556
|
Katayama M et al. |
Preliminary study of interaction of clarithromycin with tacrolimus in cats. |
2014 |
J. Vet. Med. Sci. |
pmid:25099737
|
Park CS et al. |
Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance. |
2014 |
Am. J. Gastroenterol. |
pmid:25091062
|
Cicek-Senturk G et al. |
Acute mercury poisoning presenting as fever of unknown origin in an adult woman: a case report. |
2014 |
J Med Case Rep |
pmid:25084829
|
Bilgin M et al. |
Acute coronary syndrome secondary to clarithromycin: the first case and review of the literature. |
2014 |
Turk Kardiyol Dern Ars |
pmid:25080953
|
Hsu PI et al. |
Randomized controlled trial comparing 7-day triple, 10-day sequential, and 7-day concomitant therapies for Helicobacter pylori infection. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25070099
|
Lee JW et al. |
GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea. |
2014 |
Scand. J. Gastroenterol. |
pmid:24957849
|
Raffaldi I et al. |
An atypical deep neck infection in a two-year-old child. |
2014 |
Infez Med |
pmid:24955801
|
Oh DH et al. |
Efficacy of hybrid therapy as first-line regimen for Helicobacter pylori infection compared with sequential therapy. |
2014 |
J. Gastroenterol. Hepatol. |
pmid:24955448
|
Patel K et al. |
Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity. |
2014 |
Int J Pharm |
pmid:24954663
|
Vafaeimanesh J et al. |
Expression comparison of azithromycin and clarithromycin in triple-therapy regimens for eradication of Helicobacter pylori in hemodialysis patients. |
2014 |
Saudi J Kidney Dis Transpl |
pmid:24434382
|
Bonferoni MC et al. |
Ionic polymeric micelles based on chitosan and fatty acids and intended for wound healing. Comparison of linoleic and oleic acid. |
2014 |
Eur J Pharm Biopharm |
pmid:24384070
|
Philips RC et al. |
Mycobacterium fortuitum infection arising in a new tattoo. |
2014 |
Dermatol. Online J. |
pmid:24945647
|
Klesiewicz K et al. |
PCR-RFLP detection of point mutations A2143G and A2142G in 23S rRNA gene conferring resistance to clarithromycin in Helicobacter pylori strains. |
2014 |
Acta Biochim. Pol. |
pmid:24927236
|
Sugimoto M and Furuta T |
Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype. |
2014 |
World J. Gastroenterol. |
pmid:24914361
|
Heo J and Jeon SW |
Optimal treatment strategy for Helicobacter pylori: era of antibiotic resistance. |
2014 |
World J. Gastroenterol. |
pmid:24914324
|
Graham DY et al. |
Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. |
2014 |
Clin. Gastroenterol. Hepatol. |
pmid:23751282
|
Jarand J and Field SK |
Embrace simplicity when treating lady windermere. |
2014 |
Chest |
pmid:25091749
|
Nishida T et al. |
Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan. |
2014 |
World J. Gastroenterol. |
pmid:24764674
|
Zhou L et al. |
Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study. |
2014 |
Chin. Med. J. |
pmid:24762588
|
Luo Q et al. |
[Clinical effect of clarithromycin therapy in patients with chronic rhinosinusitis]. |
2014 |
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi |
pmid:24742507
|
Trotti LM et al. |
Further experience using clarithromycin in patients with Kleine-Levin syndrome. |
2014 |
J Clin Sleep Med |
pmid:24733995
|
Khalili N |
Sunny hypomania associated with clarithromycin: a case report. |
2014 |
J Clin Psychopharmacol |
pmid:24717249
|
Onyekwere CA et al. |
Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: report of an efficacy study. |
2014 |
World J. Gastroenterol. |
pmid:24707145
|
Wu JY et al. |
Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests. |
2014 |
World J. Gastroenterol. |
pmid:24695835
|
Sugimoto M et al. |
Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion. |
2014 |
Helicobacter |
pmid:24690010
|
Liu KY et al. |
Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24687504
|
Ikawa K et al. |
Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages. |
2014 |
J Clin Pharm Ther |
pmid:24661290
|
Varvyanskaya A and Lopatin A |
Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery. |
2014 |
Int Forum Allergy Rhinol |
pmid:24659566
|
Ali Habib HS et al. |
Effect of sequential versus standard Helicobacter pylori eradication therapy on the associated iron deficiency anemia in children. |
2013 Sep-Oct |
Indian J Pharmacol |
pmid:24130381
|
Mégraud F |
Current recommendations for Helicobacter pylori therapies in a world of evolving resistance. |
2013 Nov-Dec |
Gut Microbes |
pmid:23929066
|
Suzaki I et al. |
Enhancement of thioredoxin production from nasal epithelial cells by the macrolide antibiotic, clarithromycin in vitro. |
2013 May-Jun |
In Vivo |
pmid:23606690
|
Dajani AI et al. |
Do probiotics improve eradication response to Helicobacter pylori on standard triple or sequential therapy? |
2013 May-Jun |
Saudi J Gastroenterol |
pmid:23680708
|
Petitto J et al. |
Successful clarithromycin desensitization in a macrolide-sensitive pediatric patient. |
2013 May-Jun |
J Allergy Clin Immunol Pract |
pmid:24565493
|
Cottle LE et al. |
A multinational outbreak of histoplasmosis following a biology field trip in the Ugandan rainforest. |
2013 Mar-Apr |
J Travel Med |
pmid:23464714
|
Molina-Infante J and Gisbert JP |
[Update on the efficacy of triple therapy for Helicobacter pylori infection and clarithromycin resistance rates in Spain (2007-2012)]. |
2013 Jun-Jul |
Gastroenterol Hepatol |
pmid:23623461
|
Razafimahefa SH et al. |
[Helicobacter pylori: what eradication regimen in a tropical area after the failure of two separate lines of eradication including metronidazole and clarithromycin?]. |
2013 Jan-Mar |
Med Sante Trop |
pmid:23360589
|
Mandras N et al. |
Antibacterial efficacy and drug-induced tooth discolouration of antibiotic combinations for endodontic regenerative procedures. |
2013 Apr-Jun |
Int J Immunopathol Pharmacol |
pmid:23755774
|
Guo L et al. |
Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. |
2013 |
Toxicol. Sci. |
pmid:24052561
|
Yano K et al. |
Clinical outcome of the chronic flexor tenosynovitis in the hand caused by non-tuberculous mycobacterium treated by extensive tenosynovectomy and drugs. |
2013 |
J Plast Surg Hand Surg |
pmid:23875916
|
Seck A et al. |
Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients. |
2013 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:23298145
|
Yula E et al. |
Detection of primary clarithromycin resistance of Helicobacter pylori and association between cagA (+) status and clinical outcome. |
2013 |
Folia Microbiol. (Praha) |
pmid:22956464
|
Zhou L et al. |
Cutaneous Mycobacterium intracellulare infection in an immuno-competent person. |
2013 |
Acta Derm. Venereol. |
pmid:23532357
|
Cai M et al. |
Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumonia. |
2013 |
Immunobiology |
pmid:23199585
|
Georgopoulos SD et al. |
Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area. |
2013 |
Helicobacter |
pmid:23714140
|